805 resultados para ames MPF
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Background: Crotalaria pallida Ailton is a plant belonging to the Fabaceae family, popularly known as rattle or rattlesnake and used in traditional medicine to treat swelling of the joints and as a vermifuge. Previous pharmacological studies have also reported anti-inflammatory, antimicrobial and antifungal activities. Nevertheless, scientific information regarding this species is scarce, and there are no reports related to its possible estrogenic and mutagenic effects. Thus, the purpose of the present study was to investigate the estrogenic potential of C. pallida leaves by means of the Recombinant Yeast Assay (RYA), seeking an alternative for estrogen replacement therapy during menopause; and to reflect on the safe use of natural products to assess the mutagenic activity of the crude extract from C. pallida leaves, the dichloromethane fraction and stigmasterol by means of the Ames test.Methods: The recombinant yeast assay with the strain BY4741 of Saccharomyces cerevisiae, was performed with the ethanolic extract, dichloromethane fraction and stigmasterol isolated from the leaves of C. pallida. Mutagenic activity was evaluated by the Salmonella/microsome assay (Ames test), using the Salmonella typhimurium tester strains TA100, TA98, TA97 and TA102, with (+S9) and without (-S9) metabolization, by the preincubation method.Results: All samples showed estrogenic activity, mainly stigmasterol. The ethanolic extract from C. pallida leaves showed mutagenic activity in the TA98 strain (-S9), whereas dichloromethane fraction and stigmasterol were found devoid of activity.Conclusion: Considering the excellent estrogenic activity performed by stigmasterol in the RYA associated with the absence of mutagenic activity when evaluated by the Ames test, stigmasterol becomes a strong candidate to be used in hormone replacement therapy during menopause. © 2013 Boldrin et al.; licensee BioMed Central Ltd.
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Flavonoides são constituintes fenólicos de plantas que possuem diversas atividades terapêuticas, dentre elas, a atividade antimutagênica. Eles são caracterizados por um esqueleto carbônico C6-C3-C6, em que os componentes C6 são anéis aromáticos e o C3 um anel heterocíclico. Diferenças nessa estrutura podem alterar a atividade e o seu potencial antimutagênico. Para melhor compreensão da atividade antimutagênica exercida pelos flavonoides, neste estudo, os compostos quercetina, kaempferol, luteolina, fisetina, galangina, crisina, flavona, 3-hidroxiflavona, 5-hidroxiflavona e 7-hidroxiflavona, flavonoides que apresentam diferenças no padrão de hidroxilação, foram analisados pelo teste de Ames. Para realização dos ensaios foram utilizadas as cepas TA98, TA100 e TA102 de Salmonella typhimurium em testes com e sem ativação metabólica. Os mutágenos utilizados para comparação do efeito protetor dos flavonoides foram 4-nitro-o-fenilenodiamina (NPD), azida sódica (AZS), mitomicina C (MMC), benzo[a]pireno (B[a]P), aflatoxina B1 (AFB1) e 2-aminoantraceno (2-AA). No ensaio contra o NPD sem ativação metabólica, todos os flavonoides apresentaram efeito antimutagênico, com exceção da fisetina. No ensaio com ativação metabólica contra o B[a]P, todos os flavonoides demonstraram forte efeito antimutagênico, com exceção da quercetina que potencializou o efeito mutagênico do mutágeno. No ensaio contra a AZS sem ativação metabólica, os flavonoides luteolina, crisina, 3-hidroxiflavona e 7-hidroxiflavona reduziram a resposta mutagênica do mutágeno. No ensaio contra a AFB1 com ativação metabólica, os flavonoides kaempferol, luteolina, crisina e galangina (em concentrações mais elevadas) exibiram efeito antimutagênico ...
Resumo:
Não disponível
Resumo:
Processo FAPESP
Resumo:
In the neotropical savannah, Astronium species are used in popular medicine to treat allergies, inflammation, diarrhea and ulcers. Given that natural products are promising starting points for the discovery of novel potentially therapeutic agents, the aim of the present study was to investigate the mutagenic and antimutagenic activities of hydroalcoholic extracts of Astronium spp. The mutagenicity was determined by the Ames test on Salmonella typhimurium strains TA98, TA97a, TA100 and TA102. The antimutagenicity was tested against the direct-acting and indirect-acting mutagens. The results showed that none of the extracts induce any increase in the number of revertants, demonstrating the absence of mutagenic activity. On the other hand, the results on the antimutagenic potential showed a moderate inhibitory effect against NPD and a strong protective effect against B[a]P and AFB1. This study highlights the importance of screening species of Astronium for new medicinal compounds. The promising results obtained open up new avenues for further study and provide a better understanding the mechanisms by which these species act in protecting DNA from damage. However, further pharmacological and toxicological investigations of crude extracts of Astronium spp., as well as of its secondary metabolites, are necessary to determine the mechanism(s) of action to guarantee their safer and more effective application to human health.
Resumo:
Genotoxicity data on commercial azo dyes and their components remain sparse, despite their widespread use. We have tested the mutagenicity of 2-cyano-4-nitroaniline (CNNA) and 2,6-dicyano-4-nitroaniline (CNCNNA), components of azo dyes such as Disperse Blue 165 and Disperse Red 73, in Ames test strains. Both compounds are extraordinarily potent frameshift mutagens, with much greater activity than structurally similar dihalonitroanilines and halodinitroanilines. Analysis of the responses of strains over-expressing or deficient in bioactivation enzymes shows that bacterial nitroreductase and acetyl CoA: arylamine N-acetyltransferase are important mediators of the mutagenicity of CNNA and CNCNNA. Environ. Mol. Mutagen., 2015. © 2015 Wiley Periodicals, Inc.